Camarda Financial Advisors’s Colgate-Palmolive CL Stock Holding History

Camarda Financial Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Sell	2,852 -300	-10%	-$26.2K	0.08%	115
2026 Q1	$269K	Buy	+3,152	New	+$281K	0.14%	98
2019 Q3	–	Sell	-28	Closed	-$2K	–	116
2019 Q2	$2K	Hold	28	–	–	﹤0.01%	316
2019 Q1	$2K	Buy	+28	New	+$1.81K	﹤0.01%	338
2017 Q3	–	Sell	-45	Closed	-$3K	–	211
2017 Q2	$3K	Buy	+45	New	+$3.34K	﹤0.01%	211
2015 Q2	–	Sell	-18	Closed	-$1K	–	227
2015 Q1	$1K	Hold	18	–	–	﹤0.01%	234
2014 Q4	$1K	Hold	18	–	–	﹤0.01%	251
2014 Q3	$1K	Hold	18	–	–	﹤0.01%	198
2014 Q2	$1K	Hold	18	–	–	﹤0.01%	203
2014 Q1	$1K	Hold	18	–	–	﹤0.01%	185
2013 Q4	$1K	Buy	+18	New	+$1.15K	﹤0.01%	168

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Camarda Financial Advisors's CL Position: Q2 2026 in Review

Camarda Financial Advisors reduced its Colgate-Palmolive (CL) stake by 9.5% in Q2 2026, selling an estimated $26.2K and leaving 2,852 shares worth $261K. The position accounts for 0.08% of the portfolio, ranked #115.

Camarda Financial Advisors first reported a position in CL in Q4 2013 and has held it in 11 quarters since. The position peaked at $269K in Q1 2026. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Camarda Financial Advisors held 2,852 shares of Colgate-Palmolive worth $261K as of Q2 2026.
Camarda Financial Advisors sold 300 Colgate-Palmolive shares in Q2 2026, an estimated $26.2K.
Colgate-Palmolive made up 0.08% of Camarda Financial Advisors's portfolio in Q2 2026, its #115 holding.
Camarda Financial Advisors first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 11 quarters since.
Camarda Financial Advisors's Colgate-Palmolive position peaked at $269K in Q1 2026.
2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Camarda Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.